Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers in Montreal and NYU partner on new COVID-19 clinical study

April 8, 2020

Catalyst announces pivotal phase III design for MarzAA

April 8, 2020

CellCentric enters agreement with PCCTC for phase II dose-expansion study of CCS-1477

April 8, 2020

FDA approves the initiation of stem cell study for protection against COVID-19

April 8, 2020

Phase IIa study of golexanolone shows no clinical benefit

April 8, 2020

Stopping tau in its tracks

April 8, 2020

Minimal phenotyping gives minimal insights into MDD genetics

April 8, 2020

Aviptadil enters clinical trials to treat COVID-19-related ARDS

April 7, 2020

Crinetics reports interim data from phase II ACROBAT EDGE trial of paltusotine in acromegaly

April 7, 2020

PKX-001 demonstrates safety and efficacy in dry eye disease model

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...